Literature DB >> 2446645

Heterogeneous epithelial expression of class II (HLA-DR) determinants and secretory component related to dysplasia in ulcerative colitis.

T O Rognum1, P Brandtzaeg, K Elgjo, O Fausa.   

Abstract

The intensity and degree of heterogeneous epithelial marker expression were evaluated immunohistochemically in 29 mucosal biopsy specimens from 7 ulcerative colitis (UC) patients with dysplasia. Biopsy specimens from UC patients with mild (n = 7) or severe (n = 6) inflammation and from histologically normal samples (n = 7) served as controls. HLA-DR showed heterogeneous epithelial expression in all lesions with high grade dysplasia and in 6 of 8 with low grade dysplasia. SC was heterogeneous stained in 17 of 21 lesions with high grade dysplasia and in all but two lesions with low grade dysplasia. In histologically normal mucosa, SC was homogeneously expressed and epithelial DR was virtually absent. In mildly inflamed UC lesions, SC exhibited patchy distribution in only one sample and DR in two, whereas both SC and DR showed a slight degree of heterogeneous expression in all lesions with severe inflammation. Moreover, the overall intensity of SC staining tended to decrease with increasing degree of inflammation, whereas the opposite was seen for DR. Decreased SC and increased DR expression thus seemed to be related to intensified inflammatory activity, whereas heterogeneous expression of these markers was significantly more related to dysplasia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2446645      PMCID: PMC2001837          DOI: 10.1038/bjc.1987.217

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  29 in total

1.  Immunoglobulin-producing cells in the "transitional" mucosa adjacent to adenocarcinomas of the human large bowel.

Authors:  T O Rognum; P Brandtzaeg; K Baklien; J Hognestad
Journal:  Int J Cancer       Date:  1979-02       Impact factor: 7.396

2.  "Precancer" lesions in ulcerative colits. A retrospective study of rectal biopsy and colectomy specimens.

Authors:  J H Yardley; D F Keren
Journal:  Cancer       Date:  1974-09       Impact factor: 6.860

3.  Anomolous expression of HLA-DR antigens on human colorectal cancer cells.

Authors:  A S Daar; S V Fuggle; A Ting; J W Fabre
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

4.  Immunohistochemical evaluation of carcinoembryonic antigen, secretory component, and epithelial IgA in ulcerative colitis with dysplasia.

Authors:  T O Rognum; K Elgjo; O Fausa; P Brandtzaeg
Journal:  Gut       Date:  1982-02       Impact factor: 23.059

5.  Enhancement by cholera toxin of IgA secretion from intestinal crypt epithelium.

Authors:  S R Hamilton; D F Keren; J K Boitnott; S M Robertson; J H Yardley
Journal:  Gut       Date:  1980-05       Impact factor: 23.059

6.  Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins.

Authors:  L M Sollid; D Kvale; P Brandtzaeg; G Markussen; E Thorsby
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

7.  Tissue demonstration of carcinoembryonic antigen (CEA) in ulcerative colitis.

Authors:  P Isaacson
Journal:  Gut       Date:  1976-07       Impact factor: 23.059

8.  In situ identification of inflammatory cells in malignant, non-lymphoid human tumours.

Authors:  J L Svennevig
Journal:  Acta Pathol Microbiol Scand A       Date:  1980-11

9.  Immunoperoxidase study of the secretory immunoglobulin system in colonic neoplasia.

Authors:  P Isaacson
Journal:  J Clin Pathol       Date:  1982-01       Impact factor: 3.411

10.  Fluorescence staining of gastric mucosa. A study with special reference to parietal cells.

Authors:  R Stave; P Brandtzaeg
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

View more
  7 in total

Review 1.  Lymphoepithelial interactions in the mucosal immune system.

Authors:  P Brandtzaeg; L M Sollid; P S Thrane; D Kvale; K Bjerke; H Scott; K Kett; T O Rognum
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

2.  Relation between T cell number and epithelial HLA class II expression quantified by image analysis in normal and inflamed human gastric mucosa.

Authors:  K Valnes; H S Huitfeldt; P Brandtzaeg
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

3.  K-ras mutations and HLA-DR expression in large bowel adenomas.

Authors:  S Norheim Andersen; J Breivik; T Løvig; G I Meling; G Gaudernack; O P Clausen; A Schjölberg; O Fausa; F Langmark; E Lund; T O Rognum
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

4.  Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis.

Authors:  S N Andersen; T O Rognum; E Lund; G I Meling; S Hauge
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

5.  Flow cytometric DNA ploidy pattern in dysplastic mucosa, and in primary and metastatic carcinomas in patients with longstanding ulcerative colitis.

Authors:  G I Meling; O P Clausen; A Bergan; A Schjølberg; T O Rognum
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

6.  HLA-DR antigen expression in colorectal carcinomas: influence of expression by IFN-gamma in situ and its association with tumour progression.

Authors:  K Matsushita; T Takenouchi; S Kobayashi; H Hayashi; K Okuyama; T Ochiai; A Mikata; K Isono
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

7.  Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis.

Authors:  T Løvig; S N Andersen; L Thorstensen; C B Diep; G I Meling; R A Lothe; T O Rognum
Journal:  Br J Cancer       Date:  2002-09-23       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.